Pulmonary Arterial Hypertension ：Focusing on a Future: Enhancing and Extending Life ( Solvay Pharmaceuticals Conferences )

Publication subTitle ：Focusing on a Future: Enhancing and Extending Life

Publication series ： Solvay Pharmaceuticals Conferences

Author： Antel J.;Hesselink M.B.;Schermuly R.T.  

Publisher： Ios Press‎

Publication year： 2010

E-ISBN: 9781607506096

P-ISBN(Paperback): 9781607506010

Subject： R56 Respiratory and thoracic diseases

Keyword： 呼吸系及胸部疾病

Language： ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

Pulmonary hypertension is a fatal lung and heart disease. It is characterized by shortness of breath, fatigue and fainting. It is exacerbated by an increase of the pressure in the lung vasculature through exercise, leading to progressive worsening of hemodynamics, right ventricular hypertrophy, right heart insufficiency and finally right heart failure. This book focuses on pulmonary arterial hypertension, a rare and progressive subgroup of pulmonary hypertension, which is today incurable and terminally fatal. Classification of pulmonary arterial hypertension, its pathology, and strategies for future therapy will be of interest both to those suffering from the disease and those who take care of patients. This volume will also engage physicians and other scientists contributing to an understanding of the pathophysiology of pulmonary arterial hypertension and attempting to extend life of humans with pulmonary arterial hypertension by developing causal and curative therapies.

Chapter

Title page

Preface

List of Contributors

Contents

Conference Preface

Surgical Treatment of Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension Associated with Systemic Sclerosis: A Need for a More Focused Approach

Established and New Therapies for Hypoxia and Non-Hypoxia-Related Pulmonary Hypertension

Novel Anti-Proliferative Therapies in Pulmonary Hypertension

What Animal Models Tell Us About Treatments for Pulmonary Hypertension

Therapeutic Potential for Dual Inhibition of Endothelin Converting Enzyme and Neutral Endopeptidase in Pulmonary Arterial Hypertension

Pulmonary Vascular Disease in the Newborn - From Pathophysiology to Therapeutic Strategies

From Concept to Therapy - Alternative Route of Drug Application: Inhalation

Author Index

The users who browse this book also browse


No browse record.